WO1994021240A3 - Superparamagnetische teilchen, verfahren zu ihrer herstellung und verwendung derselben - Google Patents
Superparamagnetische teilchen, verfahren zu ihrer herstellung und verwendung derselben Download PDFInfo
- Publication number
- WO1994021240A3 WO1994021240A3 PCT/DE1994/000314 DE9400314W WO9421240A3 WO 1994021240 A3 WO1994021240 A3 WO 1994021240A3 DE 9400314 W DE9400314 W DE 9400314W WO 9421240 A3 WO9421240 A3 WO 9421240A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- superparamagnetic
- pct
- particles
- aggregates
- group containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
- A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
- A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
- A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
- A61K49/1851—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule
- A61K49/1857—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule the organic macromolecular compound being obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. PLGA
- A61K49/186—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule the organic macromolecular compound being obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. PLGA the organic macromolecular compound being polyethyleneglycol [PEG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
- A61K49/1887—Agglomerates, clusters, i.e. more than one (super)(para)magnetic microparticle or nanoparticle are aggregated or entrapped in the same maxtrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5094—Microcapsules containing magnetic carrier material, e.g. ferrite for drug targeting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
- B03C1/00—Magnetic separation
- B03C1/005—Pretreatment specially adapted for magnetic separation
- B03C1/01—Pretreatment specially adapted for magnetic separation by addition of magnetic adjuvants
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y25/00—Nanomagnetism, e.g. magnetoimpedance, anisotropic magnetoresistance, giant magnetoresistance or tunneling magnetoresistance
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/14—Enzymes or microbial cells immobilised on or in an inorganic carrier
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
- G01N33/5434—Magnetic particles using magnetic particle immunoreagent carriers which constitute new materials per se
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01F—MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
- H01F1/00—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties
- H01F1/0036—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties showing low dimensional magnetism, i.e. spin rearrangements due to a restriction of dimensions, e.g. showing giant magnetoresistivity
- H01F1/0045—Zero dimensional, e.g. nanoparticles, soft nanoparticles for medical/biological use
- H01F1/0054—Coated nanoparticles, e.g. nanoparticles coated with organic surfactant
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01F—MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
- H01F1/00—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties
- H01F1/01—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of inorganic materials
- H01F1/03—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of inorganic materials characterised by their coercivity
- H01F1/12—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of inorganic materials characterised by their coercivity of soft-magnetic materials
- H01F1/34—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of inorganic materials characterised by their coercivity of soft-magnetic materials non-metallic substances, e.g. ferrites
- H01F1/36—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of inorganic materials characterised by their coercivity of soft-magnetic materials non-metallic substances, e.g. ferrites in the form of particles
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01F—MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
- H01F1/00—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties
- H01F1/44—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of magnetic liquids, e.g. ferrofluids
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01F—MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
- H01F1/00—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties
- H01F1/44—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of magnetic liquids, e.g. ferrofluids
- H01F1/445—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of magnetic liquids, e.g. ferrofluids the magnetic component being a compound, e.g. Fe3O4
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2446/00—Magnetic particle immunoreagent carriers
- G01N2446/20—Magnetic particle immunoreagent carriers the magnetic material being present in the particle core
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2446/00—Magnetic particle immunoreagent carriers
- G01N2446/80—Magnetic particle immunoreagent carriers characterised by the agent used to coat the magnetic particles, e.g. lipids
- G01N2446/84—Polymer coating, e.g. gelatin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2446/00—Magnetic particle immunoreagent carriers
- G01N2446/80—Magnetic particle immunoreagent carriers characterised by the agent used to coat the magnetic particles, e.g. lipids
- G01N2446/86—Magnetic particle immunoreagent carriers characterised by the agent used to coat the magnetic particles, e.g. lipids the coating being pre-functionalised for attaching immunoreagents, e.g. aminodextran
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/28—Details of apparatus provided for in groups G01R33/44 - G01R33/64
- G01R33/281—Means for the use of in vitro contrast agents
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6520523A JPH08508721A (ja) | 1993-03-17 | 1994-03-17 | 超常磁性粒子、その製法及びその用途 |
US08/530,132 US5916539A (en) | 1993-03-02 | 1994-03-17 | Superparamagnetic particles, process for producing the same and their use |
DE59403734T DE59403734D1 (de) | 1993-03-17 | 1994-03-17 | Superparamagnetische teilchen, verfahren zu ihrer herstellung und verwendung derselben |
EP94912435A EP0689430B1 (de) | 1993-03-17 | 1994-03-17 | Superparamagnetische teilchen, verfahren zu ihrer herstellung und verwendung derselben |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4309333A DE4309333A1 (de) | 1993-03-17 | 1993-03-17 | Superparamagnetische Teilchen, Verfahren zu ihrer Herstellung und Verwendung derselben |
DEP4309333.7 | 1993-03-17 | ||
DEP4407338.0 | 1994-03-02 | ||
DE4407338A DE4407338A1 (de) | 1993-03-17 | 1994-03-02 | Superparamagnetische Teilchen und deren Verwendung |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1994021240A2 WO1994021240A2 (de) | 1994-09-29 |
WO1994021240A3 true WO1994021240A3 (de) | 1994-10-13 |
Family
ID=25924241
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DE1994/000314 WO1994021240A2 (de) | 1993-03-02 | 1994-03-17 | Superparamagnetische teilchen, verfahren zu ihrer herstellung und verwendung derselben |
Country Status (6)
Country | Link |
---|---|
US (1) | US5916539A (de) |
EP (1) | EP0689430B1 (de) |
JP (1) | JPH08508721A (de) |
AT (1) | ATE156706T1 (de) |
DE (1) | DE59403734D1 (de) |
WO (1) | WO1994021240A2 (de) |
Families Citing this family (123)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6088613A (en) * | 1989-12-22 | 2000-07-11 | Imarx Pharmaceutical Corp. | Method of magnetic resonance focused surgical and therapeutic ultrasound |
GB9216082D0 (en) * | 1992-07-28 | 1992-09-09 | Univ Nottingham | Lymphatic delivery composition |
US20010055581A1 (en) | 1994-03-18 | 2001-12-27 | Lawrence Tamarkin | Composition and method for delivery of biologically-active factors |
JP4018141B2 (ja) * | 1995-11-01 | 2007-12-05 | ブラッコ・リサーチ・ソシエテ・アノニム | Nmr画像形成用の標的磁気標識分子マーカーシステム |
ES2239349T3 (es) | 1996-01-10 | 2005-09-16 | Amersham Health As | Medio de contraste. |
GB9600427D0 (en) * | 1996-01-10 | 1996-03-13 | Nycomed Imaging As | Contrast media |
DE19600744A1 (de) * | 1996-01-11 | 1997-07-17 | Werner Alois Prof Dipl Kaiser | Magnetische Substanz zur lokalen hyperthermischen Behandlung vorwiegend kleiner Tumore |
DE19612001A1 (de) * | 1996-03-18 | 1997-09-25 | Silica Gel Gmbh Adsorptions Te | Superparamagnetische Teilchen mit vergrößerter R¶1¶-Relaxivität, Verfahren zur Herstellung und deren Verwendung |
US5855868A (en) * | 1996-04-01 | 1999-01-05 | Nycomed Imaging As | Method of T1 -weighted resonance imaging of RES organs |
DE19622628A1 (de) * | 1996-06-05 | 1997-12-11 | Boehringer Mannheim Gmbh | Stabilisierung von Metallkonjugaten |
JP3662347B2 (ja) * | 1996-06-10 | 2005-06-22 | 日鉄鉱業株式会社 | 医療用粉体 |
PT915738E (pt) * | 1996-08-05 | 2002-07-31 | Schering Ag | Processo para a preparacao de meios de contraste para tomografia de ressonancia magnetica |
US20060003163A1 (en) * | 1996-11-16 | 2006-01-05 | Nanomagnetics Limited | Magnetic fluid |
US6986942B1 (en) | 1996-11-16 | 2006-01-17 | Nanomagnetics Limited | Microwave absorbing structure |
US6815063B1 (en) | 1996-11-16 | 2004-11-09 | Nanomagnetics, Ltd. | Magnetic fluid |
US6713173B2 (en) | 1996-11-16 | 2004-03-30 | Nanomagnetics Limited | Magnetizable device |
GB2319253A (en) | 1996-11-16 | 1998-05-20 | Eric Leigh Mayes | Composition, for use in a device, comprising a magnetic layer of domain-separated magnetic particles |
US6689485B2 (en) * | 1997-01-17 | 2004-02-10 | The Penn State Research Foundation | Powerful reductant for decontamination of groundwater and surface streams |
GB9715770D0 (en) | 1997-07-25 | 1997-10-01 | Nycomed Imaging As | Process |
US7229841B2 (en) | 2001-04-30 | 2007-06-12 | Cytimmune Sciences, Inc. | Colloidal metal compositions and methods |
US6407218B1 (en) | 1997-11-10 | 2002-06-18 | Cytimmune Sciences, Inc. | Method and compositions for enhancing immune response and for the production of in vitro mabs |
US6056898A (en) * | 1998-09-22 | 2000-05-02 | Albemarle Corporation | Low dust balanced hardness antioxidant pellets and process for the production of same |
US6821456B2 (en) * | 1998-09-22 | 2004-11-23 | Albemarle Corporation | Granular polymer additives and their preparation |
US5973138A (en) * | 1998-10-30 | 1999-10-26 | Becton Dickinson And Company | Method for purification and manipulation of nucleic acids using paramagnetic particles |
US6908955B2 (en) * | 1999-07-09 | 2005-06-21 | Construction Research & Technology Gmbh | Oligomeric dispersant |
SE9903183D0 (sv) * | 1999-09-08 | 1999-09-08 | Europ I Of Science Ab | Selektivt bindande och magnetiskt påverkbara nanopartiklar för medicinskt bruk |
GB9921579D0 (de) * | 1999-09-13 | 1999-11-17 | Nycomed Imaging As | |
RU2166751C1 (ru) * | 2000-03-09 | 2001-05-10 | Никитин Петр Иванович | Способ анализа смеси биологических и/или химических компонентов с использованием магнитных частиц и устройство для его осуществления |
DE10016559A1 (de) * | 2000-04-03 | 2001-10-18 | Eucro Europe Contract Res Gmbh | System für den Transport von Aktivstoffen in einem biologischen System |
DE10017489A1 (de) * | 2000-04-07 | 2001-10-11 | Emtec Magnetics Gmbh | Magnetisches Aufzeichnungsmedium |
US20020086842A1 (en) * | 2000-06-26 | 2002-07-04 | Christian Plank | Method for transfecting cells using a magnetic field |
WO2002000870A2 (en) * | 2000-06-26 | 2002-01-03 | Christian Plank | Method for transfecting cells using a magnetic field |
DE10033583A1 (de) * | 2000-07-11 | 2002-01-24 | Bayer Ag | Superparamagnetische Perlpolymerisate |
US6515052B2 (en) * | 2001-02-23 | 2003-02-04 | Albemarle Corporation | Granular polymer additives and their preparation |
WO2003049936A1 (en) * | 2001-04-13 | 2003-06-19 | Cornell Research Foundation, Inc. | Superparamagnetic nanostructured materials |
US7074175B2 (en) | 2001-07-25 | 2006-07-11 | Erik Schroeder Handy | Thermotherapy via targeted delivery of nanoscale magnetic particles |
US7951061B2 (en) * | 2001-07-25 | 2011-05-31 | Allan Foreman | Devices for targeted delivery of thermotherapy, and methods related thereto |
US6997863B2 (en) * | 2001-07-25 | 2006-02-14 | Triton Biosystems, Inc. | Thermotherapy via targeted delivery of nanoscale magnetic particles |
US7731648B2 (en) * | 2001-07-25 | 2010-06-08 | Aduro Biotech | Magnetic nanoscale particle compositions, and therapeutic methods related thereto |
US7018849B2 (en) * | 2002-01-15 | 2006-03-28 | Piasio Roger N | Process for (A) separating biological/ligands from dilute solutions and (B) conducting an immunochromatographic assay thereof employing superparamagnetic particles throughtout |
DE10205332B4 (de) * | 2002-02-06 | 2004-02-12 | Berlin Heart Ag | Verfahren zur Herstellung von magnetischen Nanoteilchen |
US20030224038A1 (en) * | 2002-02-21 | 2003-12-04 | Page Catherine J. | Cross-linkable phosphonate-containing supramolecular complexes and their use for delivery of therapeutic and diagnostic agents |
US7054118B2 (en) * | 2002-03-28 | 2006-05-30 | Nve Corporation | Superparamagnetic field sensing devices |
DE10222481A1 (de) * | 2002-05-22 | 2003-12-04 | Eucro Europe Contract Res Gmbh | Kontrastmittel für die Verwendung in bildgebenden Verfahren |
EP1376129B1 (de) * | 2002-06-27 | 2007-10-10 | Toyo Boseki Kabushiki Kaisha | Magnetischer Träger für biologische Substanzen, Verfahren zur seiner Produktion und seiner Verwendung zur Isolierung dieser biologischen Substanzen |
JP2006502572A (ja) * | 2002-10-09 | 2006-01-19 | フェロファーマ ゲーエムベーハー フォルシュングスラボア | 安定化超常磁性粒子 |
EP1631259A4 (de) | 2002-12-18 | 2006-08-02 | Hough Ear Inst | Otologische nanotechnologie |
US20040157219A1 (en) * | 2003-02-06 | 2004-08-12 | Jianrong Lou | Chemical treatment of biological samples for nucleic acid extraction and kits therefor |
US7601491B2 (en) * | 2003-02-06 | 2009-10-13 | Becton, Dickinson And Company | Pretreatment method for extraction of nucleic acid from biological samples and kits therefor |
US20040156846A1 (en) * | 2003-02-06 | 2004-08-12 | Triton Biosystems, Inc. | Therapy via targeted delivery of nanoscale particles using L6 antibodies |
WO2004091390A2 (en) * | 2003-04-15 | 2004-10-28 | Philips Intellectual Property & Standards Gmbh | Device and method for examination and use of an electrical field in an object under examination containing magnetic particles |
US7635734B2 (en) * | 2004-02-17 | 2009-12-22 | The Children's Hospital Of Philadelphia | Photochemical activation of surfaces for attaching biomaterial |
AU2004231992B2 (en) | 2003-04-16 | 2011-04-21 | Drexel University | Magnetically controllable drug and gene delivery stents |
US9694103B2 (en) | 2003-04-16 | 2017-07-04 | The Children's Hospital Of Philadelphia | Photochemical activation of surfaces for attaching biomaterial |
US20060041182A1 (en) * | 2003-04-16 | 2006-02-23 | Forbes Zachary G | Magnetically-controllable delivery system for therapeutic agents |
US7723311B2 (en) * | 2003-06-18 | 2010-05-25 | Nanobiomagnetics, Inc. | Delivery of bioactive substances to target cells |
US8651113B2 (en) * | 2003-06-18 | 2014-02-18 | Swr&D Inc. | Magnetically responsive nanoparticle therapeutic constructs and methods of making and using |
US7344491B1 (en) | 2003-11-26 | 2008-03-18 | Nanobiomagnetics, Inc. | Method and apparatus for improving hearing |
EP1694301A4 (de) | 2003-12-02 | 2009-11-18 | Cytimmune Sciences Inc | Verfahren und zusammensetzungen zur herstellung von monoklonalen antikörpern |
US9028829B2 (en) * | 2004-02-20 | 2015-05-12 | The Children's Hospital Of Philadelphia | Uniform field magnetization and targeting of therapeutic formulations |
US7846201B2 (en) * | 2004-02-20 | 2010-12-07 | The Children's Hospital Of Philadelphia | Magnetically-driven biodegradable gene delivery nanoparticles formulated with surface-attached polycationic complex |
US8562505B2 (en) * | 2004-02-20 | 2013-10-22 | The Children's Hospital Of Philadelphia | Uniform field magnetization and targeting of therapeutic formulations |
US20060018835A1 (en) * | 2004-04-02 | 2006-01-26 | General Electric Company | Nanoparticles with inorganic core and methods of using them |
US20050239091A1 (en) * | 2004-04-23 | 2005-10-27 | Collis Matthew P | Extraction of nucleic acids using small diameter magnetically-responsive particles |
US7842281B2 (en) * | 2004-05-10 | 2010-11-30 | The Florida State University Research Foundation | Magnetic particle composition for therapeutic hyperthermia |
JP4798971B2 (ja) * | 2004-07-30 | 2011-10-19 | キヤノン株式会社 | 磁性粒子集合体およびそれを用いた標的核酸の抽出装置および抽出方法 |
US20060024776A1 (en) * | 2004-08-02 | 2006-02-02 | Mcmillian Ray | Magnetic particle capture of whole intact organisms from clinical samples |
WO2006017427A1 (en) * | 2004-08-03 | 2006-02-16 | Becton, Dickinson And Company | Use of magnetic material to fractionate samples |
CN1309779C (zh) * | 2004-09-16 | 2007-04-11 | 同济大学 | 一种生物可降解聚合物磁性复合纳米颗粒的制备方法 |
WO2006050257A2 (en) * | 2004-10-29 | 2006-05-11 | Massachusetts Institute Of Tecchnology | Detection of ion channel or receptor activity |
US9492400B2 (en) | 2004-11-04 | 2016-11-15 | Massachusetts Institute Of Technology | Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals |
JP4822702B2 (ja) * | 2004-12-24 | 2011-11-24 | 独立行政法人科学技術振興機構 | 造影剤 |
US8084275B2 (en) * | 2005-02-08 | 2011-12-27 | Fujifilm Corporation | Magnetic composite body, production method thereof, method for removing substance with mannose on its surface, and method for concentrating substance with mannose on its surface |
JP2006242597A (ja) * | 2005-02-28 | 2006-09-14 | Fuji Photo Film Co Ltd | 磁性体ナノ粒子の凝集・分散制御方法、磁性体ナノ粒子の捕集方法及び磁性体ナノ粒子含有液の処理方法 |
EP1738774A1 (de) * | 2005-06-29 | 2007-01-03 | Schering AG | Magnetische Eisenoxidpartikel enthaltende Zusammensetzungen und deren Verwendung in bildgebenden Verfahren |
EP1738773A1 (de) * | 2005-06-29 | 2007-01-03 | Schering AG | Magnetische Eisenoxidpartikel enthaltende Zusammensetzung und deren Vervendung in bildgebenden Verfahren |
US9149545B2 (en) | 2005-11-02 | 2015-10-06 | General Electric Company | Nanoparticle-based imaging agents for X-ray/computed tomography and methods for making same |
US20070122620A1 (en) * | 2005-11-02 | 2007-05-31 | General Electric Company | Nanoparticle-based imaging agents for x-ray / computed tomography and methods for making same |
US20090317802A1 (en) * | 2005-12-09 | 2009-12-24 | Bhatia Sangeeta N | Compositions and Methods to Monitor RNA Delivery to Cells |
WO2007070682A2 (en) | 2005-12-15 | 2007-06-21 | Massachusetts Institute Of Technology | System for screening particles |
FR2897064B1 (fr) * | 2006-02-07 | 2008-07-25 | Centre Nat Rech Scient | Preparation de nanoparticules de maghemite enrobees de poly(oxyde d'ethylene). |
US20090324494A1 (en) * | 2006-02-24 | 2009-12-31 | Atgen Co., Ltd | Magnetic nano-composite for contrast agent, intelligent contrast agent, drug delivery agent for simultaneous diagnosis and treatment, and separation agent for target substance |
WO2007106415A2 (en) * | 2006-03-10 | 2007-09-20 | Massachusetts Institute Of Technology | Triggered self-assembly conjugates and nanosystems |
CA2648099C (en) | 2006-03-31 | 2012-05-29 | The Brigham And Women's Hospital, Inc | System for targeted delivery of therapeutic agents |
US20070258907A1 (en) * | 2006-04-24 | 2007-11-08 | Davis Mark E | Polymer-coated paramagnetic particles |
EP2023813A4 (de) * | 2006-05-15 | 2013-03-13 | Dmitri B Kirpotin | Magnetische mikropartikel mit organischen stoffen |
WO2007133807A2 (en) | 2006-05-15 | 2007-11-22 | Massachusetts Institute Of Technology | Polymers for functional particles |
WO2007150030A2 (en) | 2006-06-23 | 2007-12-27 | Massachusetts Institute Of Technology | Microfluidic synthesis of organic nanoparticles |
US7947487B2 (en) | 2006-10-05 | 2011-05-24 | Massachusetts Institute Of Technology | Multifunctional encoded particles for high-throughput analysis |
US20080213377A1 (en) * | 2006-12-08 | 2008-09-04 | Bhatia Sangeeta N | Delivery of Nanoparticles and/or Agents to Cells |
WO2008098165A2 (en) | 2007-02-09 | 2008-08-14 | Massachusetts Institute Of Technology | Oscillating cell culture bioreactor |
WO2008124632A1 (en) | 2007-04-04 | 2008-10-16 | Massachusetts Institute Of Technology | Amphiphilic compound assisted nanoparticles for targeted delivery |
WO2008124634A1 (en) | 2007-04-04 | 2008-10-16 | Massachusetts Institute Of Technology | Polymer-encapsulated reverse micelles |
US20090068114A1 (en) | 2007-09-07 | 2009-03-12 | Yousef Haik | Noninvasive Thermometry Monitoring System |
FR2921838A1 (fr) * | 2007-10-05 | 2009-04-10 | Guerbet Sa | Nouveau procede de preparation de nanoparticules recouvertes d'une couche stabilisatrice gem-bisphosphonate couplee a des ligands de biodistribution hydrophile |
EP3424525A1 (de) | 2007-10-12 | 2019-01-09 | Massachusetts Institute Of Technology | Impfstoffnanotechnologie |
WO2009062151A1 (en) | 2007-11-08 | 2009-05-14 | Cytimmune Sciences, Inc. | Compositions and methods for generating antibodies |
US8343497B2 (en) | 2008-10-12 | 2013-01-01 | The Brigham And Women's Hospital, Inc. | Targeting of antigen presenting cells with immunonanotherapeutics |
US8591905B2 (en) | 2008-10-12 | 2013-11-26 | The Brigham And Women's Hospital, Inc. | Nicotine immunonanotherapeutics |
US8343498B2 (en) | 2008-10-12 | 2013-01-01 | Massachusetts Institute Of Technology | Adjuvant incorporation in immunonanotherapeutics |
US8277812B2 (en) | 2008-10-12 | 2012-10-02 | Massachusetts Institute Of Technology | Immunonanotherapeutics that provide IgG humoral response without T-cell antigen |
US8226845B2 (en) * | 2008-10-27 | 2012-07-24 | GM Global Technology Operations LLC | Iron powder phosphonate coating |
US8293213B2 (en) * | 2009-03-12 | 2012-10-23 | Palo Alto Research Center Incorporated | Method and apparatus for thrombus removal using magnetic particles |
AU2010254549B2 (en) | 2009-05-27 | 2016-10-20 | Selecta Biosciences, Inc. | Nanocarriers possessing components with different rates of release |
GB2472446A (en) * | 2009-08-07 | 2011-02-09 | Ct Fuer Angewandte Nanotechnologie | Metal oxide particles coated with polyethylene glycol and their synthesis |
US9205155B2 (en) | 2009-10-30 | 2015-12-08 | General Electric Company | Treating water insoluble nanoparticles with hydrophilic alpha-hydroxyphosphonic acid conjugates, the so modified nanoparticles and their use as contrast agents |
US8565892B2 (en) | 2009-10-31 | 2013-10-22 | Qteris, Inc. | Nanoparticle-sized magnetic absorption enhancers having three-dimensional geometries adapted for improved diagnostics and hyperthermic treatment |
JP5865252B2 (ja) | 2009-11-02 | 2016-02-17 | パルス セラピューティクス インコーポレイテッド | 起磁性ステーターシステム及び磁性ローターの無線制御方法 |
MX2012013713A (es) | 2010-05-26 | 2013-01-28 | Selecta Biosciences Inc | Composiciones de nanovehiculos con adyuvante no acoplado. |
CA2802049C (en) | 2010-06-07 | 2018-07-10 | Firefly Bioworks, Inc. | Scanning multifunctional particles |
US8895068B2 (en) * | 2010-12-15 | 2014-11-25 | General Electric Company | Nanoparticle composition and associated methods thereof |
BR112013013929A2 (pt) * | 2010-12-15 | 2016-09-13 | Gen Electric | composição de nanopartícula, e, processos para fabricar uma composição de nanopartícula e de formação de imagem de diagnóstico |
US8889103B2 (en) * | 2010-12-15 | 2014-11-18 | General Electric Company | Diagnostic agent composition and associated methods thereof |
WO2012142669A1 (en) * | 2011-04-20 | 2012-10-26 | The University Of Sydney | A method for the treatment of a solid tumour |
EA201490381A1 (ru) | 2011-07-29 | 2014-06-30 | Селекта Байосайенсиз, Инк. | Синтетические наноносители, которые стимулируют формирование гуморального иммунного ответа и иммунного ответа, опосредованного цитотоксическими т-лимфоцитами (ctl) |
WO2013020701A2 (en) | 2011-08-10 | 2013-02-14 | Magforce Ag | Agglomerating magnetic alkoxysilane-coated nanoparticles |
US20130244909A1 (en) | 2012-03-09 | 2013-09-19 | Firefly Bioworks, Inc. | Methods and apparatus for classification and quantification of multifunctional objects |
WO2013166024A1 (en) | 2012-04-30 | 2013-11-07 | Tufts University | Digital quantification of single molecules |
US9883878B2 (en) | 2012-05-15 | 2018-02-06 | Pulse Therapeutics, Inc. | Magnetic-based systems and methods for manipulation of magnetic particles |
DE102014106603A1 (de) | 2014-05-12 | 2015-11-12 | Verein zur Förderung von Innovationen durch Forschung, Entwicklung und Technologietransfer e.V. (Verein INNOVENT e.V.) | Verfahren und Vorrichtung zur Abreicherung von zirkulierenden Tumorzellen aus einer Zellsuspension |
US11046991B2 (en) * | 2017-04-12 | 2021-06-29 | Iowa State University Research Foundation, Inc. | Rapid preconcentration of viable bacteria using magnetic ionic liquid for PCR amplification and culture-based diagnostics |
US11918315B2 (en) | 2018-05-03 | 2024-03-05 | Pulse Therapeutics, Inc. | Determination of structure and traversal of occlusions using magnetic particles |
CN112472824A (zh) * | 2019-09-12 | 2021-03-12 | 浙江大学医学院附属第四医院 | 一种特异性靶向对比剂-mr分子影像探针及其制备与应用 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0125995A2 (de) * | 1983-05-12 | 1984-11-21 | Advanced Magnetics, Inc. | Magnetische Teilchen zur Verwendung in Trennungen |
WO1988000060A1 (en) * | 1986-07-03 | 1988-01-14 | Advanced Magnetics, Inc. | Biodegradable superparamagnetic materials used in clinical applications |
EP0284549A2 (de) * | 1987-03-24 | 1988-09-28 | Silica Gel Ges.mbH Absorptionstechnik, Apparatebau | Magnetische Flüssigkeitszusammensetzungen |
WO1990001295A1 (en) * | 1988-08-04 | 1990-02-22 | Advanced Magnetics, Incorporated | Receptor mediated endocytosis type mri contrast agents |
WO1990001899A1 (en) * | 1988-08-16 | 1990-03-08 | Advanced Magnetics, Incorporated | Vascular magnetic imaging method and agent |
US5069216A (en) * | 1986-07-03 | 1991-12-03 | Advanced Magnetics Inc. | Silanized biodegradable super paramagnetic metal oxides as contrast agents for imaging the gastrointestinal tract |
EP0516252A2 (de) * | 1991-05-28 | 1992-12-02 | INSTITUT FÜR DIAGNOSTIKFORSCHUNG GmbH AN DER FREIEN UNIVERSITÄT BERLIN | Nanokristalline magnetische Eisenoxid-Partikel zur Anwendung in Diagnostik und Therapie |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4152210A (en) * | 1971-08-27 | 1979-05-01 | Beecham Group Limited | Biologically active materials attached to a ferromagnetic support |
US3917538A (en) * | 1973-01-17 | 1975-11-04 | Ferrofluidics Corp | Ferrofluid compositions and process of making same |
US3933997A (en) * | 1974-03-01 | 1976-01-20 | Corning Glass Works | Solid phase radioimmunoassay of digoxin |
JPS5913521B2 (ja) * | 1975-06-19 | 1984-03-30 | メイトウサンギヨウ カブシキガイシヤ | 磁性酸化鉄・デキストラン複合体の製造法 |
US3970518A (en) * | 1975-07-01 | 1976-07-20 | General Electric Company | Magnetic separation of biological particles |
GB1582956A (en) * | 1976-07-30 | 1981-01-21 | Ici Ltd | Composite magnetic particles |
US4267234A (en) * | 1978-03-17 | 1981-05-12 | California Institute Of Technology | Polyglutaraldehyde synthesis and protein bonding substrates |
US4230685A (en) * | 1979-02-28 | 1980-10-28 | Northwestern University | Method of magnetic separation of cells and the like, and microspheres for use therein |
US4343901A (en) * | 1980-10-22 | 1982-08-10 | Uop Inc. | Magnetic support matrix for enzyme immobilization |
US4452773A (en) * | 1982-04-05 | 1984-06-05 | Canadian Patents And Development Limited | Magnetic iron-dextran microspheres |
US4615879A (en) * | 1983-11-14 | 1986-10-07 | Vanderbilt University | Particulate NMR contrast agents for gastrointestinal application |
GB8408127D0 (en) * | 1984-03-29 | 1984-05-10 | Nyegaard & Co As | Contrast agents |
US4767611A (en) * | 1984-07-03 | 1988-08-30 | Gordon Robert T | Method for affecting intracellular and extracellular electric and magnetic dipoles |
US4675173A (en) * | 1985-05-08 | 1987-06-23 | Molecular Biosystems, Inc. | Method of magnetic resonance imaging of the liver and spleen |
US5314679A (en) * | 1986-07-03 | 1994-05-24 | Advanced Magnetics Inc. | Vascular magnetic resonance imaging agent comprising nanoparticles |
US4925678A (en) * | 1987-04-01 | 1990-05-15 | Ranney David F | Endothelial envelopment drug carriers |
US5358702A (en) * | 1990-04-10 | 1994-10-25 | Unger Evan C | Methoxylated gel particle contrast media for improved diagnostic imaging |
US5328681A (en) * | 1991-01-19 | 1994-07-12 | Meito Sangyo Kabushiki Kaisha | Composition comprising magnetic metal oxide ultrafine particles and derivatized polysaccharides |
US5225282A (en) * | 1991-12-13 | 1993-07-06 | Molecular Bioquest, Inc. | Biodegradable magnetic microcluster comprising non-magnetic metal or metal oxide particles coated with a functionalized polymer |
US5349957A (en) * | 1992-12-02 | 1994-09-27 | Sterling Winthrop Inc. | Preparation and magnetic properties of very small magnetite-dextran particles |
-
1994
- 1994-03-17 WO PCT/DE1994/000314 patent/WO1994021240A2/de active IP Right Grant
- 1994-03-17 DE DE59403734T patent/DE59403734D1/de not_active Expired - Fee Related
- 1994-03-17 EP EP94912435A patent/EP0689430B1/de not_active Expired - Lifetime
- 1994-03-17 AT AT94912435T patent/ATE156706T1/de not_active IP Right Cessation
- 1994-03-17 US US08/530,132 patent/US5916539A/en not_active Expired - Fee Related
- 1994-03-17 JP JP6520523A patent/JPH08508721A/ja active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0125995A2 (de) * | 1983-05-12 | 1984-11-21 | Advanced Magnetics, Inc. | Magnetische Teilchen zur Verwendung in Trennungen |
US4554088A (en) * | 1983-05-12 | 1985-11-19 | Advanced Magnetics Inc. | Magnetic particles for use in separations |
WO1988000060A1 (en) * | 1986-07-03 | 1988-01-14 | Advanced Magnetics, Inc. | Biodegradable superparamagnetic materials used in clinical applications |
US5069216A (en) * | 1986-07-03 | 1991-12-03 | Advanced Magnetics Inc. | Silanized biodegradable super paramagnetic metal oxides as contrast agents for imaging the gastrointestinal tract |
EP0284549A2 (de) * | 1987-03-24 | 1988-09-28 | Silica Gel Ges.mbH Absorptionstechnik, Apparatebau | Magnetische Flüssigkeitszusammensetzungen |
WO1990001295A1 (en) * | 1988-08-04 | 1990-02-22 | Advanced Magnetics, Incorporated | Receptor mediated endocytosis type mri contrast agents |
WO1990001899A1 (en) * | 1988-08-16 | 1990-03-08 | Advanced Magnetics, Incorporated | Vascular magnetic imaging method and agent |
EP0516252A2 (de) * | 1991-05-28 | 1992-12-02 | INSTITUT FÜR DIAGNOSTIKFORSCHUNG GmbH AN DER FREIEN UNIVERSITÄT BERLIN | Nanokristalline magnetische Eisenoxid-Partikel zur Anwendung in Diagnostik und Therapie |
Non-Patent Citations (1)
Title |
---|
A ROCH ET AL.: "IN VITRO RELAXOMETRIC CHARACTERIZATION OF SUPERPARAMAGNETIC CONTRAST AGENTS", MAGMA, vol. 1, no. 2, 1993, pages 83 - 88 * |
Also Published As
Publication number | Publication date |
---|---|
JPH08508721A (ja) | 1996-09-17 |
WO1994021240A2 (de) | 1994-09-29 |
EP0689430A1 (de) | 1996-01-03 |
US5916539A (en) | 1999-06-29 |
DE59403734D1 (de) | 1997-09-18 |
ATE156706T1 (de) | 1997-08-15 |
EP0689430B1 (de) | 1997-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1994021240A3 (de) | Superparamagnetische teilchen, verfahren zu ihrer herstellung und verwendung derselben | |
Fortner et al. | C60 in water: nanocrystal formation and microbial response | |
Glasauer et al. | Sorption of Fe (hydr) oxides to the surface of Shewanella putrefaciens: cell-bound fine-grained minerals are not always formed de novo | |
EP0888545B1 (de) | Superparamagnetische teilchen mit vergrösserter r 1-relaxivität, verfahren zur herstellung und deren verwendung | |
Elkady et al. | Microwave‐assisted synthesis of magnetic hydroxyapatite for removal of heavy metals from groundwater | |
Moumen et al. | Control of the size of cobalt ferrite magnetic fluids: Mössbauer spectroscopy | |
ATE312600T1 (de) | Verfahren und system zur behandlung dispergierbarer feiner pulver | |
HUT68596A (en) | Process for preparation of rare earth phosphates and products obtained thereby | |
DE4427821A1 (de) | Superparamagnetische Teilchen und deren Verwendung | |
DK0577215T3 (da) | Fremgangsmåde til fremstilling af overflademodificerede anticancer-nanopartikler | |
AU7344294A (en) | Preparation for improving the blood supply containing hard magnetic particles | |
EP1617220A4 (de) | Partikel mit darin eingebautem magnetischen material, verfahren zu dessen herstellung, partikel für immunoassay und immunoassay-verfahren | |
Ait‐Salah et al. | Magnetic studies of the carbothermal effect on LiFePO4 | |
Nwadialo et al. | An analysis of soil components active in microaggregate stability | |
Li et al. | Hybridization and Characteristics of Fe and Fe− Co Nanoparticles with Polymer Particles | |
NL8403664A (nl) | Magnetisch opnamemedium. | |
KR20180062425A (ko) | 자성 복합체 | |
Xu Zhou et al. | Paramagnetism in Bacillus spores: Opportunities for novel biotechnological applications | |
D'Alonzo et al. | p‐Phosphonated Calix [n] arene Stabilizes Superparamagnetic Nanoparticles for Nitrate and Phosphate Uptake | |
Eremin et al. | Interference of superexchange interactions | |
Takahashi et al. | Magnetic properties of hydroxy Ni-mica intercalation | |
WO2004061011A3 (en) | Pigment agglomerates, their manufacture, and use | |
Jiménez-Pérez et al. | Environmental Applications of Iron-Containing Nanomaterials: Synthetic Routes, Structures, Compositions and Properties | |
Hadjipanayis et al. | Magnetic hysteresis in Fe-RB powders | |
Chang | Magnetization reversal process in isolated barium ferrite particles with cobalt-titanium substitution. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): JP NO US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): JP NO US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 08530132 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1994912435 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1994912435 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1994912435 Country of ref document: EP |